Cite
HARVARD Citation
Shefner, J. et al. (2016). A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and frontotemporal degeneration. 17 (5), pp. 426-435. [Online].